Capital Rx, known for its straightforward pharmacy benefit management approach, has successfully acquired a substantial $400 million investment and is undergoing a rebranding to Judi Health as the company broadens its focus beyond just pharmacy benefits, as announced on Tuesday.
The $400 million investment comprises $252 million in Series F funding spearheaded by Wellington Management and General Catalyst, with additional participation from Generation Investment Management, Growth Equity at Goldman Sachs Alternatives, 9Yards Capital, B Capital, Edison Partners, Prime Health Investments, and Transformation Capital. This funding also includes extra investments in the company’s securities, which indicates that investors are purchasing stocks from current stakeholders.
Overall, the company has successfully raised a total of $607 million in funding, leading to a current valuation of $3.25 billion.
This financing will be utilized to enhance the deployment of Judi Health’s Enterprise Health Platform, which features:
- Capital Rx: a transparent PBM specifically designed for self-insured employers
- Judi Health: a comprehensive health benefit management solution aimed at employers, TPAs, and health plans. This solution provides essential care navigation support for pharmacy, medical, vision, and dental benefits
- Judi: a software-as-a-service platform that facilitates health plans in managing their claim workflows
CEO AJ Loiacono shared with MedCity News that the company is also allocating resources towards research and development. Furthermore, the company is on the lookout for investment opportunities in firms that offer complementary technologies, while ensuring that such investments do not interfere with its core architecture or services, he explained.
When queried about Judi Health’s potential exit strategy, Loiacono mentioned that the company is not currently revealing any exit plans.
Judi Health is reportedly “scaling at the right time,” according to Wellington Capital.
“As PBM reform gains traction, employers are increasingly demanding transparency and control — and Capital Rx’s independent, technology-driven platform is designed to fulfill these needs. Their expansion into comprehensive benefit administration responds to market demands while leveraging the capabilities of AI in ways that traditional systems simply cannot,” stated Joshua Sommerfeld, healthcare sector lead at Wellington Management.
The announcement from the company arrives as employers anticipate a rise in healthcare costs in the U.S. by approximately 9% by 2026, as reported by the Business Group on Health. Rising pharmacy expenses play a significant role in this increase, prompting many to seek out transparent PBMs like Capital Rx and Navitus to mitigate this challenge.
Judi Health currently supports over 4 million employer PBM members and 54 million health plan lives. The company aims to maintain its positive growth trajectory, according to Loiacono.
“Our transition to Judi Health reflects the company’s overarching mission to provide the necessary infrastructure for the healthcare that our country deserves,” he stated. “For employers, health plans, and ultimately patients, this signifies the development of a platform that not only addresses their current needs but also adapts and evolves alongside them into the future.”
For more of the latest insights into litigation, regulations, deals, and trends in financial services, subscribe to Finance Docket, a collaboration between Breaking Media publications Above the Law and Dealbreaker.
